PoS 2
ePoster 02

Programm

• • ePoster
  • P206

  Medium-term gray matter structural longitudinal changes in patients with persistent headache after COVID-19

  • Álvaro Planchuelo-Gómez (Cardiff, GB)
• • ePoster
  • P207

  Phenotyping migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters (Part 2)

  • Stefano Di Antonio (Aalborg, DK)
• • ePoster
  • P208

  Differences in clinical characteristics, sensitization, musculoskeletal impairments, and psychological burden between migraine patients with and without neck pain

  • Matteo Castaldo (Aalborg, DK)
• • ePoster
  • P209

  Altered noradrenergic-enriched connectivity in migraine with and without aura

  • Nazia Karsan (London, GB)
• • ePoster
  • P210

  Could a surgery cure migraine? A case report showing the link between migraine and endometriosis

  • Catarina Fernandes (Coimbra, PT)
• • ePoster
  • P211

  Psychological profiles and clinical characteristics of migraine patients with early life traumas

  • Sara Bottiroli (Pavia, IT)
• • ePoster
  • P212

  Behavioural characterisation of a rodent model of migraine using preventive and acute treatments

  • Christoforos Tsantoulas (Sandwich, GB)
• • ePoster
  • P213

  Glial cells and their function in migraine chronification

  • Soodeh Razeghi Jahromi (Tehran, IR)
• • ePoster
  • P214

  Brain connectivity changes induced by monoclonal antibodies targeting the CGRP pathway in migraine patients: a prospective HD-EEG Study

  • Francescantonio Cammarota (Pavia, IT)
• • ePoster
  • P215

  Characteristics and biomarkers of headache as leading symptom of COVID-19 infection

  • Oľga Duraníková (Bratislava, SK)
• • ePoster
  • P216

  Expression of miR-155 in migraine: association with migraine phenotypes and disease severity

  • Federico Bighiani (Pavia, IT)
• • ePoster
  • P217

  Hypothalamus involvement in the migraine cycle: a task-free fMRI analysis during nitroglycerin-induced attacks

  • Daniele Martinelli (Pavia, IT)